Xefta 250 mg Inj image 1
01 / 02

Genuine Medicines

Tracked Shipping

Plain Packaging

Order Metadata
ReferenceGH·XEFTA250
AvailabilityIn stock
SourceIndia
Delivery5–10 business days to your country
GH·XEFTA250Anti-Cancer / Oncology Medicines

Xefta 250 mg Inj

Gefitinib is a prescription targeted cancer medicine used to treat non-small cell lung cancer (NSCLC) that has a specific change (mutation) in the EGFR gene. It works by blocking the abnormal EGFR protein that drives the growth of these cancer cells. It is taken by mouth once daily, with or without food. It must be used only under the supervision of a cancer specialist after the tumor has been tested for the EGFR mutation.

Order This Product

Send us a message on WhatsApp with this product name — we'll come back with the price and delivery options for your country.

Description

Gefitinib belongs to a group called tyrosine kinase inhibitors (TKIs), which block the signals that tell cancer cells to grow and multiply. It targets the epidermal growth factor receptor (EGFR) and works only in tumors that carry certain activating EGFR mutations, such as exon 19 deletions or the L858R mutation, so a tumor test is done first. It is prescribed as the first treatment for advanced or metastatic EGFR-mutation-positive NSCLC, and sometimes after earlier chemotherapy. The usual dose is one 250 mg tablet once daily at about the same time each day. The tablet should be swallowed whole with water, and if swallowing is difficult, it can be dispersed in non-carbonated water and drunk. Treatment is continued as long as it works and side effects are tolerable. Common side effects include diarrhea, acne-like skin rash, dry or itchy skin, nail changes, mouth sores, loss of appetite, nausea, and tiredness. The skin rash is common and may be linked to better response, but sun protection, moisturizers, and early treatment help control it. Loperamide and fluids help manage diarrhea, and severe or persistent diarrhea needs medical advice. Rarely, it can cause serious lung inflammation (interstitial lung disease), so new or worsening cough, breathlessness, or fever must be reported to the doctor at once. It can also cause liver problems, so liver function is checked regularly, and yellow skin or eyes, dark urine, or severe stomach pain needs urgent attention. Eye problems such as pain, redness, or vision changes should be reported promptly. Medicines that reduce stomach acid, such as omeprazole and ranitidine, can lower its absorption, so timing or avoidance may be advised. Strong CYP3A4 inducers such as rifampicin, phenytoin, and St. John’s wort can lower its levels, and inhibitors such as itraconazole can raise them, and it can increase the effect of warfarin. It can harm an unborn baby, so effective contraception is advised during treatment and for at least two weeks afterward, and breastfeeding should be avoided. The dose should never be changed or stopped without the oncologist’s advice.

Specifications

Composition
Gefitinib
Strength
250 mg
Manufacturer
Dr Reddys
Treatment
Cancer Medicine
Packaging Type
Strips
Packaging Size
1 x 10 Tablets

How this product reaches you

  1. 1Global Healthcare sources this product from a manufacturer in India. The manufacturer name and country are part of the order record.
  2. 2It is shipped from India to your address. Carrier and delivery options depend on your country and order size.
  3. 3Your country's import rules apply — we help you understand them on chat.

Similar Products